Literature DB >> 8872868

Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease.

F Takakubo1, M Yamamoto, N Ogawa, Y Yamashita, Y Mizuno, I Kondo.   

Abstract

Idiopathic Parkinson's disease (PD) is a multifactorial neuro-degenerative disorder resulting from environmental factors acting on genetically susceptible individuals with normal aging. Cytochrome P450IA1 is a dioxin-inducible enzyme which is responsible for the activation of procarcinogens and environmental pollutants, such as benzo[alpha]pyrene and other aromatic hydrocarbons. The frequencies of polymorphic alleles of cytochrome P450IA1 gene (CYPIA1) were studied in 126 unrelated patients with PD in comparison with 176 healthy Japanese. The frequency of the Msp I polymorphic allele, a variant of CYPIA1 (m2), was significantly higher in patients with PD (0.444) than in controls (0.349). The risk of PD in homozygotes for m2 was 2.34-fold greater than homozygotes for the wild-type, m1. The relative risk for PD in homozygotes for CYPIA1Val was 6.54-fold higher than in homozygotes for the wild type (CYPIA1Ile)(p < 0.001). These results strongly suggest that the CYPIA1 might be one of the susceptibility genes for PD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872868     DOI: 10.1007/BF01273362

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  22 in total

1.  Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.

Authors:  S Hayashi; J Watanabe; K Nakachi; K Kawajiri
Journal:  J Biochem       Date:  1991-09       Impact factor: 3.387

2.  Parkinson's disease. Genetic analysis and evidence of a multifactorial etiology.

Authors:  K Kondo; L T Kurland; W J Schull
Journal:  Mayo Clin Proc       Date:  1973-07       Impact factor: 7.616

3.  Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain.

Authors:  J F Ghersi-Egea; R Perrin; B Leininger-Muller; M C Grassiot; C Jeandel; J Floquet; G Cuny; G Siest; A Minn
Journal:  Biochem Pharmacol       Date:  1993-02-09       Impact factor: 5.858

Review 4.  Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins.

Authors:  F J Gonzalez; H V Gelboin
Journal:  Drug Metab Rev       Date:  1994       Impact factor: 4.518

5.  Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.

Authors:  L C Quattrochi; S T Okino; U R Pendurthi; R H Tukey
Journal:  DNA       Date:  1985-10

6.  Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP.

Authors:  D D Petersen; C E McKinney; K Ikeya; H H Smith; A E Bale; O W McBride; D W Nebert
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

7.  Electrophysiological actions of nicotine on substantia nigra single units.

Authors:  P B Clarke; D W Hommer; A Pert; L R Skirboll
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

Review 8.  Human AH locus polymorphism and cancer: inducibility of CYP1A1 and other genes by combustion products and dioxin.

Authors:  D W Nebert; D D Petersen; A Puga
Journal:  Pharmacogenetics       Date:  1991-11

9.  Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.

Authors:  M E McManus; W M Burgess; M E Veronese; A Huggett; L C Quattrochi; R H Tukey
Journal:  Cancer Res       Date:  1990-06-01       Impact factor: 12.701

10.  Addiction to nicotine is due to high intrinsic levels of dopamine.

Authors:  G W Paulson
Journal:  Med Hypotheses       Date:  1992-07       Impact factor: 1.538

View more
  4 in total

1.  Sexual dimorphism in xenobiotic genetic variants-mediated risk for Parkinson's disease.

Authors:  Nadella Kumudini; Addepally Uma; Shaik Mohammad Naushad; Rukmini Mridula; Rupam Borgohain; Vijay Kumar Kutala
Journal:  Neurol Sci       Date:  2014-01-04       Impact factor: 3.307

2.  Cytochrome P450 1B1 mRNA in the human central nervous system.

Authors:  C R Rieder; D B Ramsden; A C Williams
Journal:  Mol Pathol       Date:  1998-06

3.  Acetaldehyde and parkinsonism: role of CYP450 2E1.

Authors:  Francesca Vaglini; Cristina Viaggi; Valentina Piro; Carla Pardini; Claudio Gerace; Marco Scarselli; Giovanni Umberto Corsini
Journal:  Front Behav Neurosci       Date:  2013-06-21       Impact factor: 3.558

4.  Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson's Disease.

Authors:  Hui-Hui Fan; Bao-Qing Li; Ke-Yun Wu; Hai-Dan Yan; Meng-Jie Gu; Xing-Hao Yao; Hao-Jia Dong; Xiong Zhang; Jian-Hong Zhu
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.